Pfizer (PFE) Announces FDA Approval of sBLA for Pfizer-BioNTech COVID-19 Vaccine

Pfizer (PFE) Announces FDA Approval of sBLA for Pfizer-BioNTech COVID-19 Vaccine

Pfizer Inc. (NYSE:PFE) is one of the top most undervalued low volatility stocks to buy now. Pfizer Inc. (NYSE:PFE) announced on August 27 the US Food and Drug Administration’s (FDA) approval of the supplemental Biologics License Application (sBLA) for the companies’ LP.8.1-adapted monovalent COVID-19 vaccine (COMIRNATY® LP.8.1; COVID-19 Vaccine, mRNA). Pfizer’s (PFE) Breakthrough Medicines Power…

Read More
The S&P 500 may not be a leading economic indicator anymore. But the ‘S&P 495’ is

How Wall Street values stocks

The stock market has been on a wild march higher this year — driven by the White House’s shifting trade policy, geopolitical concerns, and conflicting economic data. The barrage of headlines — both positive and negative — is creating an intimidating backdrop. The good news? The way to value stocks stays the same, no matter…

Read More